+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Autoimmune Collaboration and Licensing Deals 2016-2023 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2023

  • Report
  • October 2023
  • 450 Pages +
  • Global
From
Immunology Collaboration and Licensing Deals 2016-2023 - Product Thumbnail Image

Immunology Collaboration and Licensing Deals 2016-2023

  • Report
  • October 2023
  • 450 Pages
  • Global
From
From
From
Global Markets for Research Antibodies - Product Thumbnail Image

Global Markets for Research Antibodies

  • Report
  • January 2024
  • 485 Pages
  • Global
From
Immunoglobulins: Global Market Outlook - Product Thumbnail Image

Immunoglobulins: Global Market Outlook

  • Report
  • March 2023
  • 64 Pages
  • Global
From
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more